Tengion, Inc. is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. The Company, by using its Organ Regeneration Platform, it creates neo-organs using patient's own cells. The Company, based on its clinical and preclinical experience is leveraging its Organ Regeneration Platform to develop Neo-Kidney Augment for patients with advanced chronic kidney disease and Neo-Urinary Conduit for bladder cancer patients who are in need of a urinary diversion. The Company's product candidates are intended to delay or eliminate the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
Phone+1-336-7225855
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Tengion (OTCMKTS:TNGN) Frequently Asked Questions
What is Tengion's stock symbol?
Tengion trades on the OTCMKTS under the ticker symbol "TNGN."
Has Tengion been receiving favorable news coverage?
Media stories about TNGN stock have been trending neutral this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tengion earned a media sentiment score of 0.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days.
Who are Tengion's key executives?
Tengion's management team includes the folowing people:
- David I. Scheer, Independent Chairman of the Board (Age 63)
- Carl-Johan Dalsgaard M.D., Independent Director (Age 56)
- Diane K. Jorkasky M.D., Independent Director (Age 61)
- Richard E. Kuntz M.D., Independent Director (Age 58)
- Lorin Jeffry Randall, Independent Director
How do I buy shares of Tengion?
Shares of TNGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tengion's official website?
How can I contact Tengion?
Tengion's mailing address is 3929 Westpoint Blvd Ste G, WINSTON SALEM, NC 27103-6761, United States. The company can be reached via phone at +1-336-7225855.
MarketBeat Community Rating for Tengion (OTCMKTS TNGN)
MarketBeat's community ratings are surveys of what our community members think about Tengion and other stocks. Vote "Outperform" if you believe TNGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TNGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
